Condition
Heart Failure With Preserved Ejection Fraction clinical trials and research
As of November 12, 2026, Find a Trial lists 53 Heart Failure With Preserved Ejection Fraction clinical trials that are recruiting, at sites in 37 countries (most in United States (29), China (6), United Kingdom (4)). 1 was first registered in the last 30 days. By phase: Phase 2 (7), Phase 4 (6), Phase 1 (2), Phase 3 (2). The most active sponsors are Mayo Clinic (3), The University of Texas Health Science Center at San Antonio (2), Wake Forest University Health Sciences (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 53Clinical trials
- 1New in 30 days
- 37Countries
Newest Heart Failure With Preserved Ejection Fraction clinical trials
All recruiting trials (53)
-
Remote rehabilitation for HFpEF patients using telerehabilitation
A home-based telerehabilitation program is being tested to see if it is safe and helpful for people with heart failure with preserved ejection fraction.
-
EDG-15400 in adults with HFpEF: a phase 2 study
This phase 2 study tests different doses of EDG-15400 against placebo in adults with HFpEF to see if it is safe and tolerable.
-
Incretin therapy with tirzepatide for obesity-related HFpEF
A 15-month study will test whether tirzepatide helps people with obesity and HFpEF by reducing plasma volume.
-
Boosted exercise with group coaching for HFpEF
This trial tests a blended, guided exercise program with group coaching and remote monitoring to see if it helps older adults with HFpEF improve activity and health at a lower cost.
-
Exercise cardiac MRI for heart failure with preserved ejection fraction
This study will try low-field exercise cardiac MRI to see if it can diagnose, describe, and predict risk in people with HFpEF compared with those who have non-cardiac breathlessness and healthy volunteers.
-
HRS-1893 for heart failure with preserved ejection fraction
This trial will test whether HRS-1893 is safe and tolerable in adults aged 40 and older who have heart failure with preserved ejection fraction.
-
Pulmonary Artery Denervation for a specific type of heart and lung pressure problem
This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.
-
Activation-ligand trap therapy with exercise to help HFpEF patients
This trial tests whether adding activin-ligand trap therapy to an exercise program can improve peak oxygen use and thinking skills in people with HFpEF.
-
HS235 study in overweight and obese people with a specific type of heart failure-related lung pressure problem
This study tests HS235 versus placebo to see if it helps overweight and obese adults with combined pre- and post-capillary pulmonary hypertension due to heart failure with preserved ejection fraction.
-
CS reducer device for symptomatic HFpEF with coronary microvascular dysfunction
This study will test whether implanting a coronary sinus (CS) reducer reduces heart muscle ischemia on stress CMR in adults with HFpEF and coronary microvascular dysfunction.
-
68Ga‑FAPI PET imaging to detect fibroblast activity in HFpEF
This test uses a PET scan with 68Ga‑FAPI to see if it can identify fibroblast activity in people with HFpEF who are obese and have exertional breathlessness.
-
Maridebart cafraglutide for people with obesity and preserved or mildly reduced ejection fraction heart failure
This trial will test whether adding maridebart cafraglutide to usual heart-failure care can reduce hospital visits, cardiovascular deaths, and improve symptoms in adults with obesity and HFpEF or HFmrEF.
-
Short Of Pace: Pacemaker pacing for heart failure with preserved ejection fraction
This trial will test whether turning on a pacemaker to raise heart rate helps people with stable HFpEF who have a low resting heart rate and chronotropic incompetence.
-
Managing congestion in heart failure with a remote monitoring device
This study is testing whether a remote monitoring device can help people with heart failure keep track of their fluid levels and improve their treatment.
-
Atrioventricular node ablation with conduction system pacing versus drug rate control for HFpEF patients with permanent atrial fibrillation
This will test whether regularizing heart rate by combining atrioventricular node ablation with physiological (conduction system) pacing lowers deaths or heart-failure hospital stays compared with medication in people with well-controlled permanent atrial fibrillation and HFpEF.
-
Early feasibility of the PeriCut Catheter System for a minimally invasive pericardiotomy in HFpEF
This will test a minimally invasive catheter procedure (PeriCut) that creates a small opening in the pericardium to try to relieve shortness of breath in people with HFpEF who have severe symptoms.
-
Using MRI to understand heart failure in patients with preserved ejection fraction and diabetes
This study is trying to see how heart failure with preserved ejection fraction affects people with type 2 diabetes by using special MRI scans to learn more about their heart's function.
-
Effect of Rifaximin on Heart Function in Patients with Heart Failure and Bacterial Overgrowth
This study is testing if the antibiotic rifaximin can help improve heart function in people with heart failure and bacterial overgrowth in their intestines.
-
Identifying heart tissue changes in patients with heart failure
This study looks at changes in heart tissue of people with heart failure to see if it can help find better treatments for their condition.
-
Exploring heart failure with preserved ejection fraction
This study is trying to gather detailed information about patients with heart failure and preserved ejection fraction to see how different factors affect their treatment and outcomes.
-
Using advanced imaging to evaluate heart muscle scarring in various heart conditions
This study is testing a new imaging method to see how heart scarring changes over time in people with certain heart conditions.
-
Leg heat therapy for improving heart function in patients with preserved ejection fraction
This study is testing if a new leg heat therapy can help people with heart failure feel stronger and exercise better.
-
Evaluating Qishen Granules for Heart Failure with Preserved Ejection Fraction
This study is testing if Qishen Granules can help improve heart function and quality of life for people with heart failure that has preserved ejection fraction.
-
Increasing dietary fiber in patients with heart failure and diabetes
This study tests if adding potato starch to the diets of people with heart failure and diabetes can improve their gut health and overall well-being.
-
Improving Vascular Function in Veterans with Heart Failure
This study is testing whether a combination of L-Citrulline, BH4, and atorvastatin can help improve blood flow and physical ability in Veterans with heart failure.
-
Testing methods for diagnosing heart failure with preserved ejection fraction
This study is testing new ways to diagnose heart failure with preserved ejection fraction in people who have trouble breathing during exercise to see if they can improve current methods.
-
Improving exercise capacity in heart failure patients using conduction system pacing
This study is testing if a new type of heart pacing can help people with heart failure exercise better than the standard pacing method.
-
Using empagliflozin to treat heart failure in patients with end-stage renal disease
This study tests if the drug empagliflozin can help people with heart failure and severe kidney disease who are on dialysis feel better and improve their heart health.
-
Colchicine to restore microvascular function in heart failure with preserved ejection fraction
This study tests whether taking colchicine daily can improve heart blood flow in people with heart failure and a preserved ejection fraction compared to a placebo.
-
Investigating arterial stiffening's role in heart failure with preserved ejection fraction
This study is trying to see if measuring how stiff the arteries are can help identify people at risk for developing heart failure with preserved ejection fraction.
-
Evaluating heart muscle stiffness in patients with heart failure
This study is testing how stiff the heart muscle is in people with heart failure to see how it affects their heart function and the chances of needing to go back to the hospital.
-
Comparing ketogenic and low-fat diets for heart failure patients
This study is testing whether a low carbohydrate ketogenic diet or a low-fat diet can help people with heart failure feel better and exercise more effectively over six months.
-
Evaluating the effects of bariatric surgery on heart failure and atrial fibrillation
This study is testing if bariatric surgery can improve heart health and quality of life for obese patients who have heart failure and atrial fibrillation compared to standard care.
-
Gene therapy for heart failure with preserved ejection fraction
This study is testing a new gene therapy to see if it can help people with heart failure feel better by improving how their heart relaxes and fills with blood.
-
Exploring heart health in postmenopausal women
This study looks at how changes in estrogen levels may affect heart health in postmenopausal women and could lead to heart failure.
-
Effects of Ferric Derisomaltose on Exercise and Quality of Life in Heart Failure Patients
This study is testing if adding Ferric Derisomaltose to regular treatment can help people with heart failure and low iron feel better and exercise more easily.
-
Effects of weight loss on heart health in obese patients with heart failure
This study tests if losing weight can help improve heart health in overweight or obese people with heart failure.
-
HeartShare combines various data to improve heart failure treatment
This study is trying to see if using different types of health data can help doctors create better, personalized treatments for people with heart failure.
-
Effects of Pioglitazone on Heart Failure in Obese Type 2 Diabetics
This study is testing if the diabetes drug Pioglitazone can help improve heart function in obese people with type 2 diabetes and heart failure.
-
Improving breathing and exercise capacity in heart failure patients with obesity
This study is testing if breathing a special helium-oxygen gas mixture can help people with heart failure and obesity breathe better and exercise more easily.
-
Using blood samples to identify heart failure risks in diabetes patients
This study is trying to see if blood tests can help find out which people with type 2 diabetes are at risk for heart failure.
-
Optimizing beta-blocker use in older adults with heart failure
This study is trying to see if a personalized approach to adjusting beta-blocker medication can help older adults with heart failure feel more confident in their treatment and manage their condition better.
-
Using lower-body negative pressure to improve exercise tolerance in heart failure patients
This study is testing if a special technique that reduces blood flow in the legs can help people with heart failure feel less short of breath and exercise better.
-
Rehabilitation for older patients with heart failure
This study is testing a new physical rehabilitation program for older patients with heart failure to see if it helps them stay out of the hospital and improves their mobility.
-
Catheter ablation for atrial fibrillation in heart failure patients
This study is testing if catheter ablation can help heart failure patients with atrial fibrillation avoid serious heart problems better than standard medication.
-
Evaluating exercise testing for diagnosing heart issues in patients with exertional dyspnea
This study is testing a new way to diagnose heart problems in people who get short of breath during exercise by using special tests that look at how the heart and lungs work together.
-
Stopping beta-blockers in heart failure with preserved ejection fraction
This pilot will try stopping beta-blockers for about 4 weeks in people with HFpEF to see if symptoms, walking distance, and heart function change.
-
Testing Empagliflozin and Potassium Nitrate for Heart Failure with Preserved Ejection Fraction
This study is testing if a combination of two medications, Empagliflozin and Potassium Nitrate, can help people with heart failure feel stronger and exercise better.
-
Evaluating Cardiac Contractility Modulation in Heart Failure Patients
This study is testing a new heart treatment called Cardiac Contractility Modulation to see if it can help people with heart failure feel better and improve their heart function.
-
Effects of SGLT2 Inhibitors and Ketones on Heart and Muscle Health
This study is testing if a diabetes medication can change ketone levels in people with Type 2 Diabetes and heart failure to see how it affects their heart and muscle health over 12 weeks.
-
Improving exercise endurance in heart failure patients
This study is testing if Potassium Nitrate, with or without extra supplements, can help people with heart failure improve their exercise endurance and muscle function.
-
Monitoring heart failure patients in real-time at Yale New Haven Health System
This study is trying to see how real-time monitoring of heart failure patients at Yale New Haven Health System can help improve their care and treatment.
-
Testing spironolactone for heart failure with preserved ejection fraction
This study is testing if adding spironolactone to standard care can help people with heart failure and preserved ejection fraction live longer and avoid hospital visits.
Related topics
Quick answers
How many Heart Failure With Preserved Ejection Fraction clinical trials are recruiting right now?
53, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 37 countries. The most sites are in United States (29 trials), China (6 trials), United Kingdom (4 trials), Germany (4 trials), Canada (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 7, Phase 4: 6, Phase 1: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.